Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019

A Maniakas, R Dadu, NL Busaidy, JR Wang… - JAMA …, 2020 - jamanetwork.com
Importance Anaplastic thyroid carcinoma (ATC) historically has a 4-month median overall
survival (OS) from time of diagnosis, with disease-specific mortality approaching 100%. The
association between recent major advancements in treatment and OS has yet to be
evaluated. Objective To evaluate rates of OS in patients with ATC over the last 2 decades.
Design, Setting, and Participants Retrospective cohort study in a single tertiary care
institution. Patients with histopathological confirmation of ATC from January 2000 to October …